HIMS & HERS HEALTH INC (HIMS) Stock Price, Quote, News and Overview
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
HIMS Quote, Performance and Key Statistics
HIMS & HERS HEALTH INC
NYSE:HIMS (2/4/2025, 8:04:00 PM)
After market: 41.85 0 (0%)41.85
+2.92 (+7.5%)
The current stock price of HIMS is 41.85 USD. In the past month the price increased by 57.15%. In the past year, price increased by 324.01%.
HIMS Latest News, Press Releases and Analysis
Unlocking the Growth Potential of NYSE:HIMS.
A fundamental analysis of (NYSE:HIMS): Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
Why the high growth investor may take a look at NYSE:HIMS.
Unlocking the high Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).
Hims & Hers Launches Health Collective and Community Member Council
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.
HIMS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 10.66 | 81.07B | ||
| CVS | CVS HEALTH CORP | 8.87 | 70.91B | ||
| LH | LABCORP HOLDINGS INC | 17.11 | 20.63B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.31 | 18.23B | ||
| DVA | DAVITA INC | 19.97 | 14.54B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 176.57 | 14.45B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 14.89 | 14.42B | ||
| CHE | CHEMED CORP | 24.34 | 8.35B | ||
| CRVL | CORVEL CORP | 26.46 | 6.40B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
| OPCH | OPTION CARE HEALTH INC | 25.97 | 5.26B | ||
| RDNT | RADNET INC | 110.08 | 4.97B |
Related stock screener links
About HIMS
Company Profile
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,046 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. The company offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. The company offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.
Company Info
HIMS & HERS HEALTH INC
2269 Chestnut St, #523
San Francisco CALIFORNIA 94123 US
CEO: Andrew Dudum
Employees: 1046
Company Website: https://www.forhims.com/
Investor Relations: https://investors.forhims.com/
Phone: 14158510195
HIMS FAQ
What is the stock price of HIMS?
The current stock price of HIMS is 41.85 USD.
What is the symbol for HIMS & HERS HEALTH INC stock?
The exchange symbol of HIMS & HERS HEALTH INC is HIMS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is HIMS stock listed?
HIMS stock is listed on the New York Stock Exchange, Inc. exchange.
Is HIMS a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for HIMS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of HIMS.
Does HIMS stock pay dividends?
HIMS does not pay a dividend.
What is the Price/Earnings (PE) ratio of HIMS?
The PE ratio for HIMS is 95.11. This is based on the reported non-GAAP earnings per share of 0.44 and the current share price of 41.85 USD.
What is the Short Interest ratio of HIMS stock?
The outstanding short interest for HIMS is 30.7% of its float.
HIMS Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to HIMS. When comparing the yearly performance of all stocks, HIMS is one of the better performing stocks in the market, outperforming 98.73% of all stocks.
HIMS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to HIMS. While HIMS has a great health rating, its profitability is only average at the moment.
HIMS Financial Highlights
Over the last trailing twelve months HIMS reported a non-GAAP Earnings per Share(EPS) of 0.44. The EPS increased by 358.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.15% | ||
| ROA | 16.81% | ||
| ROE | 23.01% | ||
| Debt/Equity | 0 |
HIMS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 72% to HIMS. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 596.09% and a revenue growth 68.1% for HIMS